What is Haemonetics's price / earnings?

Haemonetics (HAE) reported price / earnings of 21.4× in Q4 2025.

How has Haemonetics's price / earnings changed year-over-year?

Haemonetics's price / earnings decreased by 29.1% year-over-year, from 30.2× to 21.4×.

What is the long-term trend for Haemonetics's price / earnings?

Over 4 years (2021 to 2025), Haemonetics's price / earnings has grown at a -28.1% compound annual growth rate (CAGR), from 71.4× to 19×.

What does price / earnings mean?

Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.

Haemonetics HAE Price / earnings

Price / earnings at other companies

AbbottABT

28.4×+11.4×

TFX

TeleflexTFX

27.7×-9.9×

Boston ScientificBSX

26.2×-47.5×

MedtronicMDT

21.7×-1.5×

LivaNovaLIVN

39.8×-119×

Merit Medical SystemsMMSI

29.4×-21.5×

Other financials

Income statement

See full

Revenue$346.4M+4.8%

Gross profit$198.2M+2.7%

Operating income$67.4M+14.2%

Net income$44.7M+19.3%

EPS (diluted)$0.95+28.4%

Balance sheet

See full

Cash & equivalents$245.4M-20.0%

Total debt$1.3B-0.7%

Total equity$796.3M-3.0%

Total assets$2.4B-2.2%

Cash flow

See full

Operating cash flow$70.9M-39.1%

CapEx$17.7M+12.9%

Free cash flow$53.3M-47.2%

Valuation

See full

Market cap$3.37B-18.0%

Enterprise value$4.4B-12.5%

P/S2.5×-0.5×

Profitability

See full

Gross margin59%+4.0pp

Operating margin19%+5.9pp

Net margin13.3%+3.8pp

FCF margin19.5%+9.1pp

Returns & leverage

See full

Return on equity19.3%+5.2pp

Debt / equity1.6×0.0×

Current ratio3×+1.3×

Where this comes from

Calculated from Haemonetics’s reported figures.

market cap/net income=21.4×

Based on the most recent quarter.

The official record: Haemonetics’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Haemonetics's price / earnings?: Haemonetics (HAE) reported price / earnings of 21.4× in Q4 2025.
How has Haemonetics's price / earnings changed year-over-year?: Haemonetics's price / earnings decreased by 29.1% year-over-year, from 30.2× to 21.4×.
What is the long-term trend for Haemonetics's price / earnings?: Over 4 years (2021 to 2025), Haemonetics's price / earnings has grown at a -28.1% compound annual growth rate (CAGR), from 71.4× to 19×.
What does price / earnings mean?: Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.